Skip to main content
Premium Trial:

Request an Annual Quote

Celera Announces Three New Academic Subscribers to its Database

NEW YORK - October 18 - Celera Genomics has signed The Weizmann Institute of Science in Israel, the California Institute of Technology, and The Institute for Genomic Research as subscribers to its database , the Rockville, Md., company announced Wednesday.

Each institution has signed a multi-year subscription to Celera Discovery System, which provides Web-based access to Celera’s database of human, mouse, and drosophila genomic information.

The financial terms of the agreements were not disclosed. Celera has previously stated that academic subscribers pay between $6,000 and $15,000 per scientist for access to its database.

" We are pleased that Celera's expanding genomic databases and related proprietary software can now be accessed by these three renowned, international institutions," Craig Venter, Celera's president and chief scientific officer, said in a statement. " Having access to this information should enable researchers at these institutions to make important discoveries and possible advances in the field of medicine."

The other publicly disclosed academic subscribers to Celera’s database include Howard Hughes Medical Institute, The University of Texas Southwestern Medical Center at Dallas, The University of Cincinnati, Ohio State University, The Australian National Health and Medical Research Council,and Vanderbilt University.

Additionally, several pharmaceutical companies pay between $5 and $15 million each to access Celera's database through custom portals at their facilities.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.